EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA AFTER TREATMENT WITHDRAWAL

被引：0
|
作者：
Jimenez, R. [1 ]
Cicero, S. [1 ]
Bron, M. [1 ]
Shah, C. [1 ]
Angelov, A. S. [1 ]
机构：
[1] Neurocrine Biosci Inc, San Diego, CA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB31
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] Long-Term Effects of Valbenazine on Tardive Dyskinesia in Older and Younger Adults
    Alexopoulos, George S.
    Sajatovic, Martha
    Sheth, Bijal
    Siegert, Scott
    Farahmand, Khodayar
    Burke, Joshua
    Liang, Grace S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S158 - S159
  • [32] TARDIVE-DYSKINESIA AFTER WITHDRAWAL OF TRIFLUOPERAZINE THERAPY
    JEFFERSON, JW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (11): : 1633 - 1634
  • [33] Valbenazine granted breakthrough drug status for treating tardive dyskinesia
    Mueller, Thomas
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (06) : 737 - 742
  • [34] Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia
    Davis, Michael C.
    Miller, Brian J.
    Kalsi, Jasmeet K.
    Birkner, Thomas
    Mathis, Mitchell V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (26): : 2503 - 2506
  • [35] CLINICAL EFFICACY OF VALBENAZINE AND DEUTETRABENAZINE FOR THE TREATMENT OF TARDIVE DYSKINESIA: INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS
    Aggarwal, S.
    Serbin, M.
    Yonan, C.
    VALUE IN HEALTH, 2019, 22 : S272 - S272
  • [36] Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
    Praharaj, Samir Kumar
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (01) : 93 - 93
  • [37] A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
    Factor, Stewart
    Hauser, Robert
    Mandri, Daniel
    Castro-Gayol, Julio
    Jimenez, Roland
    Siegert, Scott
    O'Brien, Christopher
    NEUROLOGY, 2016, 86
  • [38] Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Citrome, Leslie
    Singer, Carlos
    Lindenmayer, Jean-Pierre
    Zinger, Celia
    Liang, Grace
    Dunayevich, Eduardo
    Marder, Stephen R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (04) : 353 - 361
  • [39] TARDIVE AND WITHDRAWAL DYSKINESIA ASSOCIATED WITH HALOPERIDOL
    JACOBSON, G
    BALDESSARINI, RJ
    MANSCHRECK, T
    AMERICAN JOURNAL OF PSYCHIATRY, 1974, 131 (08): : 910 - 913
  • [40] Valbenazine and deutetrabenazine: Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia
    Khorassani, Farah
    Luther, Kiranjit
    Talreja, Om
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (03) : 167 - 174
12345